| 2018 | YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma | 김상겸, 신상준, 최은아 |
| 2018 | Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective | 금웅섭, 김남규, 민병소, 신상준, 안중배, 윤홍인, 임준석, 장지석, 최서희, 허혁 |
| 2018 | Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection | 김기열, 김남규, 범승훈, 신상준, 안중배, 정민규 |
| 2017 | Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer | 금웅섭, 김남규, 김영진, 김지형, 김호근, 민병소, 범승훈, 신상준, 안중배, 정민규, 허수진 |
| 2017 | Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
| 신상준, 정민규 |
| 2017 | Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
| 노미령, 박규현, 신상준, 정기양 |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| 김태수, 노재경, 라선영, 박규현, 신상준, 안중배, 정현철, 정희철 |
| 2017 | Quality of life among Korean gastrointestinal cancer survivors
| 김상희, 박창기, 신상준, 추상희 |
| 2017 | Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer
| 금웅섭, 김남규, 김용배, 민병소, 신상준, 안중배, 임준석, 장지석, 최서희, 허혁 |
| 2017 | Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
| 금웅섭, 김남규, 김지형, 김호근, 민병소, 박형순, 신상준, 안중배, 정민규, 정인경, 최은아, 허수진, 허혁 |
| 2017 | IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
| 민병소, 신상준, 한윤대 |
| 2017 | Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition | 김은경, 김한상, 신상준, 정기양, 정민규, 조병철 |
| 2017 | A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors | 김건민, 라선영, 신상준, 안중배, 정현철 |
| 2016 | p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer | 김남규, 김태일, 노재경, 라선영, 박규현, 신상준, 안중배, 이강영 |
| 2016 | A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis | 금웅섭, 김남규, 김태일, 김호근, 신상준, 안중배, 정민규 |
| 2016 | Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy | 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박준철, 범승훈, 손태일, 신상준, 신성관, 이상길, 이용찬, 임준석, 정민규, 정재호, 정현수, 정현철, 최윤영, 형우진 |
| 2016 | Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
| 금웅섭, 김남규, 김태일, 김호근, 신상준, 안중배, 윤홍인, 정민규 |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | 김남규, 라선영, 신상준, 안중배, 이강영, 정현철, 정희철 |
| 2016 | A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach
| 박경희, 박중원, 박혜정, 범승훈, 신상준, 이재현, 정민규 |
| 2016 | Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers | 금웅섭, 김남규, 김주훈, 김지형, 김호근, 민병소, 박형순, 범승훈, 신상준, 안중배, 정민규, 허수진 |
| 2016 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
| 김명진, 박미숙, 신상준, 안중배 |
| 2016 | Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification | 금기창, 김세헌, 신상준, 이정심, 장지석 |
| 2016 | Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer | 김대준, 박형순, 범승훈, 신상준, 안중배, 이민구, 이진구, 이창영, 정민규, 허수진 |
| 2015 | Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
| 김수희, 김효송, 노재경, 라선영, 신규호, 신상준, 안중배, 양우익, 유철주, 임선민, 정현철, 조용진, 한정우 |
| 2015 | PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity | 권우선, 김남규, 라선영, 박찬희, 신상준, 안중배, 양우익, 정현철 |
| 2015 | Incorporation of radiotherapy in the multidisciplinary treatment of isolated retroperitoneal lymph node recurrence from colorectal cancer | 금기창, 금웅섭, 김남규, 김태일, 신상준, 안중배, 이정심, 임준석, 장지석 |
| 2015 | Novel methods for clinical risk stratification in patients with colorectal liver metastases | 김남규, 노재경, 민병소, 백승혁, 신상준, 안중배, 이강영, 임준석, 차인호, 최기홍, 최진섭, 허혁 |
| 2015 | Clinical implications from a single-center study of colorectal adenocarcinoma in transplant recipients | 김남규, 민병소, 백세진, 백승혁, 신상준, 안중배, 임선민, 정민규, 허혁 |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| 김혜련, 김효송, 노미령, 라선영, 신상준, 안중배, 이충근, 정민규, 정현철, 최혜진, 허수진 |
| 2015 | A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer | 금기창, 금웅섭, 김남규, 김태일, 김호근, 노재경, 민병소, 백승혁, 신상준, 안중배, 임준석, 정민규, 정인경, 허혁, 홍성필 |
| 2014 | Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers | 금기창, 금웅섭, 김남규, 김용배, 민병소, 신상준, 안중배, 윤홍인, 이강영 |
| 2014 | A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer | 신상준, 정현철 |
| 2014 | Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. | 김남규, 김민성, 김창우, 민병소, 백세진, 백승혁, 신상준, 안중배, 정민규, 조민수, 허혁 |
| 2014 | High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
| 김남규, 라선영, 신상준, 안중배, 정현철 |
| 2014 | Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus | 신상준 |
| 2013 | Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent | 노재경, 라선영, 신상준, 안중배, 정현철, 황지원 |
| 2013 | The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients | 김종훈, 노미령, 신상준, 조병철 |
| 2013 | Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after Drug-Eluting Stent Implantation
| 고영국, 김병극, 김중선, 신동호, 신상준, 양영준, 장양수, 최동훈, 홍명기 |
| 2013 | The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial | 김광준, 신상준, 양우익, 이병완, 장혁재, 차봉수, 최동훈 |
| 2013 | Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes
| 김현창, 박성하, 신상준, 이상학, 이한철, 장양수, 장혁재, 전계원, 조인정 |
| 2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | 김기열, 김남규, 노재경, 라선영, 신상준, 안중배, 정현철, 차인호 |
| 2013 | Efficacy and safety of the preclose technique following percutaneous aortic stent-graft implantation | 고영국, 신상준, 장양수, 최동훈, 홍명기 |
| 2013 | Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents | 고영국, 권혁문, 김병극, 김중선, 신동호, 신상준, 윤영원, 장양수, 최동훈, 홍명기 |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진 |
| 2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | 김기열, 노재경, 라선영, 박찬희, 신상준, 안중배, 임선민, 정현철 |
| 2013 | Changing treatment patterns in elderly patients with resectable colon cancer | 강버들, 김건민, 김남규, 김민환, 김한상, 노재경, 라선영, 신상준, 안중배, 정현철 |
| 2013 | Automated Quantification of Mitral Regurgitation by Three Dimensional Real Time Full Volume Color Doppler Transthoracic Echocardiography: A Validation with Cardiac Magnetic Resonance Imaging and Comparison with Two Dimensional Quantitative Methods
| 손장원, 신상준, 심지영, 장혁재, 정남식, 허란, 홍그루 |
| 2013 | Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications | 신상준, 안중배, 유철주 |
| 2013 | Impact of Atorvastatin Treatment in First-Degree Relatives of Patients With Premature Coronary Artery Disease With Endothelial Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial | 강대용, 박성하, 신상준, 심지영, 장혁재, 정남식, 조인정, 하종원, 홍그루, 홍성진 |
| 2013 | Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients | 권우선, 김혜련, 김효송, 라선영, 박형순, 신상준, 안중배, 이지현, 임선민 |
| 2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | 김효송, 라선영, 신상준, 안중배, 윤상현, 이혜정 |
| 2013 | Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study | 강대용, 김남규, 김세현, 김태일, 김현기, 노재경, 민병소, 신상준, 안중배, 이강영, 정현철, 허혁 |
| 2013 | Quantitation and pharmacokinetics of 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio) butadiene (U0126) in rat plasma by liquid chromatography-tandem mass spectrometry | 신상준, 황지원 |
| 2013 | Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
| 김주항, 김한상, 김현기, 신상준, 최혜진 |
| 2012 | Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria | 김명진, 김여은, 박미숙, 백송이, 신상준, 정우석, 최진영 |
| 2012 | Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry | 노재경, 라선영, 신상준, 안중배, 임선민, 정현철, 황지원 |
| 2012 | Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience.
| 김남규, 김태일, 노재경, 라선영, 신상준, 안중배, 정민규, 정인경, 정현철 |
| 2012 | Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis.
| 김남규, 김호근, 민병소, 신상준, 이강영, 천재희, 허혁 |
| 2012 | Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial. | 김세현, 신상준, 안중배 |
| 2012 | Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis.
| 김효송, 노재경, 라선영, 신상준, 이하영, 임승택, 한정우, 홍수정 |
| 2012 | Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea. | 신상준 |
| 2012 | Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. | 금기창, 김기황, 김남규, 김명진, 백송이, 서진석, 신상준, 임준석 |
| 2012 | VIPoma that arose from the rectum in a 65-year-old male patient. | 노재경, 신상준, 안중배, 임승택, 조인래, 조중현, 한민석 |
| 2012 | A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy. | 김혜련, 노재경, 라선영, 박경수, 신상준, 안중배, 이윤정, 정현철 |
| 2012 | A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy. | 김혜련, 노재경, 라선영, 신상준, 안중배, 정민규, 정현철, 정희철 |
| 2012 | Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging | 김경식, 김명진, 박미숙, 신상준, 최기홍, 최진섭, 최진영 |
| 2012 | Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer | 김남규, 노재경, 민병소, 백승혁, 신상준, 안중배, 이강영, 최기홍, 최진섭, 허혁 |
| 2012 | Treatment outcome of patients with anaplastic thyroid cancer: a single center experience
| 강상욱, 금기창, 김주항, 남기현, 박정수, 신상준, 임선민, 정웅윤, 조병철, 조재용 |
| 2011 | Brain metastases from colorectal carcinoma: prognostic factors and outcome | 노재경, 라선영, 서창옥, 신상준, 안중배, 장종희, 정민규, 홍수정 |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| 노성훈, 노재경, 라선영, 신상준, 안중배, 양우익, 임종근, 정현철, 정희철 |
| 2011 | Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer | 노성훈, 노재경, 라선영, 신상준, 정현철, 정희철 |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | 김기열, 김효송, 라선영, 신상준, 안중배, 정현철, 정희철, 홍민희 |
| 2011 | Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer | 노재경, 신상준, 안중배, 정재헌 |
| 2011 | Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases.
| 금기창, 금웅섭, 김남규, 민병소, 신상준, 안중배, 윤홍인, 이강영 |
| 2011 | Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer | 금기창, 김경아, 김기황, 김남규, 김명진, 김영철, 서진석, 신상준, 임준석 |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| 김효송, 노성훈, 노재경, 라선영, 박형순, 신상준, 전홍재, 정현철, 정희철 |
| 2011 | Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity | 노재경, 라선영, 신규호, 신상준, 이영주, 정민규, 정재헌, 홍수정 |
| 2011 | Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer | 강정현, 금기창, 김남규, 김호근, 민병소, 신상준, 이강영, 허혁 |
| 2011 | Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis | 김남규, 김진수, 김혜련, 노재경, 라선영, 민병소, 신상준, 안중배 |
| 2011 | DNA methylation predicts recurrence from resected stage III proximal colon cancer
| 김남규, 신상준, 안중배, 정현철 |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철 |
| 2010 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer
| 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철 |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | 노성훈, 노재경, 라선영, 신상준, 안중배, 임종근, 정현철, 정희철 |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | 금기창, 김남규, 김호근, 노재경, 라선영, 백승혁, 신상준, 안중배, 임준석, 정현철, 정희철, 천재희, 최혜진 |
| 2010 | Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators | 노재경, 라선영, 문용화, 신상준, 심효섭, 장현 |
| 2010 | A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer | 노재경, 라선영, 박경수, 신상준, 안중배, 정현철, 정희철 |
| 2010 | Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial | 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정민규, 정재헌, 조병철, 최혜진 |
| 2010 | The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
| 금기창, 금웅섭, 김남규, 김용배, 김준원, 민병소, 성진실, 신상준, 안중배 |
| 2010 | A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy
| 김건민, 김주훈, 신상준, 윤상현, 정은석, 정희철 |
| 2009 | Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials | 노성훈, 노재경, 라선영, 박찬희, 신상준, 안중배, 정현철, 정희철 |
| 2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | 노성훈, 노재경, 라선영, 신상준, 안중배, 임종근, 정현철, 정희철 |
| 2009 | Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck | 금기창, 김세헌, 김주항, 신상준, 조병철, 최은창, 최혜진 |
| 2009 | Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea
| 김찬, 김효송, 라선영, 신상준, 안정련, 안중배, 전홍재, 정현철, 홍민희 |
| 2009 | Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC | 김세현, 김주항, 손주혁, 신상준, 유내춘, 조병철, 최혜진 |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| 라선영, 박세미, 신상준, 안중배, 이상길, 정현철, 정희철 |
| 2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | 금기창, 김남규, 노재경, 라선영, 백승혁, 신상준, 안중배, 전성하, 정현철, 정희철, 천재희, 최혜진 |
| 2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | 노재경, 라선영, 신상준, 안중배, 유내춘, 정현철, 정희철, 조병철, 최혜진 |
| 2008 | The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer | 노재경, 라선영, 신상준, 안중배, 정현철, 정희철, 조병철, 최혜진 |
| 2008 | Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. | 김세규, 김주항, 손주혁, 신상준, 장준, 전성하, 정종열, 조병철, 최혜진 |
| 2008 | Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
| 노성훈, 노재경, 라선영, 신상준, 임종근, 정현철, 정희철 |
| 2008 | The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. | 김대준, 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정경영, 조병철, 최혜진 |
| 2008 | Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer | 노성훈, 노재경, 라선영, 신상준, 안중배, 유내춘, 정현철, 정희철 |
| 2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | 김세현, 노재경, 라선영, 신상준, 안중배, 이혜원B, 정현철, 정희철, 조병철, 최혜진 |
| 2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| 노성훈, 노재경, 라선영, 신상준, 안중배, 정현철, 정희철 |
| 2007 | Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib | 김세규, 김유진, 김주항, 김호근, 박무석, 박종필, 손주혁, 신상준, 임종근, 장준, 조병철, 최혜진 |
(Yonsei Health Research Network)
